Fox Christine

Track

Insider profile

Fox Christine's trades of Teva Pharmaceutical Industries Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-04 2026-04-30
S Sale
36,439 -14.0%
496.19
US$4,324,583 		36,439 -14.0% 496.19 US$4,324,583
2026-04-30 2026-04-30
PrS Proposed sale
45,940
393.20
US$4,031,868 		45,940 393.20 US$4,031,868
2026-03-09 2026-03-05
PlS Planned sale
92,031 -19.8%
31.37
US$2,269,452 		92,031 -19.8% 31.37 US$2,269,452
2026-03-05 2026-03-05
PrS Proposed sale
7,924
31.67
US$250,940 		7,924 31.67 US$250,940
2026-03-06 2026-03-04
PlS Planned sale
9,098 -10.8%
32.46
US$295,362 		9,098 -10.8% 32.46 US$295,362
2026-03-04 2026-03-04
PrS Proposed sale
9,908
32.46
US$321,658 		9,908 32.46 US$321,658
2025-11-24 2025-11-20
PlS Planned sale
28,229 -30.7%
24.78
US$699,523 		28,229 -30.7% 24.78 US$699,523
2025-11-20 2025-11-20
PrS Proposed sale
28,229
24.78
US$699,523 		28,229 24.78 US$699,523
2025-11-18 2025-11-14
S Sale
30,000 -51.4%
25.11
US$753,321 		30,000 -51.4% 25.11 US$753,321
2025-11-14 2025-11-14
PrS Proposed sale
30,000
25.11
US$753,321 		30,000 25.11 US$753,321
2025-03-06 2025-03-05
PlS Planned sale
2,147 -3.5%
15.91
US$34,166 		2,147 -3.5% 15.91 US$34,166
2025-03-06 2025-03-04
PlS Planned sale
4,034 -6.2%
15.73
US$63,473 		4,034 -6.2% 15.73 US$63,473
2025-03-04 2025-03-04
PrS Proposed sale
6,181
16.00
US$98,896 		6,181 16.00 US$98,896
2024-11-21 2024-11-20
PlS Planned sale
19,388 -30.5%
16.87
US$327,085 		19,388 -30.5% 16.87 US$327,085
2024-11-20 2024-11-20
PrS Proposed sale
19,388
16.87
US$327,085 		19,388 16.87 US$327,085